Motivational interviewing fails to raise walking distance in black adults with PAD - Healio

Motivational interviewing fails to raise walking distance in black adults with PAD  Healio

Motivational interviewing was not effective in improving walking distance for black adults with peripheral artery disease in either 6- or 12-month intervals, ...



Comments

Post a Comment

Popular posts from this blog

Could GLP-1 RAs Improve COVID-19-Induced Pulmonary Arterial Hypertension? - AJMC.com Managed Markets Network

Image
Recent studies show that glucagon-like peptide-1 receptor agonists have anti-inflammatory effects in human and rodent pathological models, making them a potential therapeutic strategy for treating pulmonary arterial hypertension after COVID-19 infection. Glucagon-like peptide-1 (GLP-1) is a hormone well-known for regulating blood sugar, and GLP-1 receptor agonists (GLP-1RAs) have been used in treatment for type 2 diabetes. But recent research shows that GLP-1RAs have anti-inflammatory effects in human and rodent models that might make them a novel therapeutic strategy for treating pulmonary arterial hypertension (PAH) after COVID-19 infection. In many cases, patients with COVID-19 experience a cytokine storm — a systemic inflammatory syndrome caused by elevated levels of circulating cytokines. It is a leading cause of inflammatory lung damage, pneumonia, and death in COVID-19 patients. A recent article published in Medical Hypotheses noted that even in patients who recover from COVID-1...
Read more